文献速递新发突发、热带与寄生虫病

恶性疟原虫氯喹耐药转运蛋白新突变与哌喹敏感性下降相关

Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity.
PubMed 文献 · J Infect Dis · 2017-01-01

研究对来自柬埔寨为主的183份恶性疟原虫样本进行全基因组关联分析,检测33716个SNP与哌喹体外敏感性的关联。发现多个染色体SNP与哌喹IC90相关,其中PfCRT基因新突变F145I在调整plasmepsin II/III扩增后仍与双氢青蒿素-哌喹治疗失败相关。结论提示除plasmepsin II/III拷贝数外,pfcrt等位点也可能参与哌喹耐药。

要点

  • PfCRT F145I突变与哌喹体外敏感性下降及双氢青蒿素-哌喹治疗失败相关。
  • plasmepsin II/III基因扩增同样与哌喹敏感性下降相关。
  • 除plasmepsin II/III拷贝数外,pfcrt等位点可能参与哌喹耐药。

核心结论

  • 除plasmepsin II/III拷贝数外,包括pfcrt在内的其他位点也可能参与哌喹耐药。

研究设计与样本

  • 对来自柬埔寨为主的183份恶性疟原虫样本在33716个全基因组SNP上进行基因分型,采用线性混合模型和随机森林估计寄生虫基因型与哌喹敏感性的关联。
  • 在独立数据集中评估候选多态性与双氢青蒿素-哌喹治疗结局的关联。

主要发现

  • 全基因组分析中多个染色体上的SNP与哌喹90%抑制浓度(IC90)相关。
  • 对全基因组分析涉及的区域精细定位发现多个相互连锁不平衡的SNP与哌喹IC90显著相关,包括PfCRT基因新突变F145I。
  • 调整plasmepsin II/III扩增后,F145I仍与双氢青蒿素-哌喹治疗失败相关;plasmepsin II/III扩增也与哌喹敏感性下降相关。

关键数值与推荐

  • 183份样本,33716个全基因组SNP,哌喹体外敏感性以IC90评估。
  • F145I突变在调整plasmepsin II/III扩增后与双氢青蒿素-哌喹治疗失败相关。

临床怎么用

  • 在监测哌喹耐药时,除plasmepsin II/III拷贝数外,可关注pfcrt F145I等位点。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Amplified copy number in the plasmepsin II/III genes within Plasmodium falciparum has been associated with decreased sensitivity to piperaquine. To examine this association and test whether additional loci might also contribute, we performed a genome-wide association study of ex vivo P. falciparum susceptibility to piperaquine. METHODS: Plasmodium falciparum DNA from 183 samples collected primarily from Cambodia was genotyped at 33716 genome-wide single nucleotide polymorphisms (SNPs). Linear mixed models and random forests were used to estimate associations between parasite genotypes and piperaquine susceptibility. Candidate polymorphisms were evaluated for their association with dihydroartemisinin-piperaquine treatment outcomes in an independent dataset. RESULTS: Single nucleotide polymorphisms on multiple chromosomes were associated with piperaquine 90% inhibitory concentrations (IC90) in a genome-wide analysis. Fine-mapping of genomic regions implicated in genome-wide analyses identified multiple SNPs in linkage disequilibrium with each other that were significantly associated with piperaquine IC90, including a novel mutation within the gene encoding the P. falciparum chloroquine resistance transporter, PfCRT. This mutation (F145I) was associated with dihydroartemisinin-piperaquine treatment failure after adjusting for the presence of amplified plasmepsin II/III, which was also associated with decreased piperaquine sensitivity. CONCLUSIONS: Our data suggest that, in addition to plasmepsin II/III copy number, other loci, including pfcrt, may also be involved in piperaquine resistance.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Agrawal S, Moser KA, Morton L, et al. Association of a Novel Mutation in the Plasmodium falciparum Chloroquine Resistance Transporter With Decreased Piperaquine Sensitivity. J Infect Dis. 2017. PMID: 28931241. doi:10.1093/infdis/jix334

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。